Duchenne Muscular Dystrophy - A biopsychosocial approach

Physiotherapy

Volumn 90, Issue 3, 2004, Pages 145-150

  Morrow, Marina ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Duchenne Muscular Dystrophy; Feelings; Lifestyle; Perception

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; COPING BEHAVIOR; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; EMOTION; FAMILY COUNSELING; HEALTH CARE NEED; HUMAN; MALE; NEUROMUSCULAR DISEASE; PATIENT CARE; PEDIATRICIAN; PHYSICAL ACTIVITY; PHYSIOTHERAPIST; PHYSIOTHERAPY; PRIORITY JOURNAL; SEXUALITY; SOCIAL ASPECT; SOCIAL PSYCHOLOGY;

EID: 4544319126     PISSN: 00319406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physio.2004.03.004     Document Type: Article

References (25)

1. Gard G, Gyllensten AL, Salford E, Ekdahl C. Physical therapists' emotional expressions in interviews about factors important for interaction with patients. Physiotherapy 2000;86(5):229-40.
2. Mead J. Patient partnership. Physiotherapy 2000;86(6):282-4.
3. Tecklin JS. Paediatric physical therapy. 3rd ed. Philadelphia: Lippincott; 1999 [chapter 6].
4. Buchanan D, LaBarbera C, Roelofs R, Olson W. Reactions of families to children with Duchenne Muscular Dystrophy. Gen Hosp Psychiatry 1979;3:262-9.
5. Witte R. The psychosocial impact of a progressive physical handicap and terminal illness (Duchenne Muscular Dystrophy) on adolescents and their families. Br J Med Psychol 1985;58:179-187.
6. Polakoff RJ, Morton AA, Koch KD, Rios CM. The psychosocial and cognitive impact of Duchenne Muscular Dystrophy. Semin Paediatr Neurol 1998;5(2):116-23.
7. Siegel IM. The management of muscular dystrophy: a clinical review. Muscle Nerve 1978:453-60.
8. Hilton T, Orr R, Perkin R, Ashwal S. End of life care in Duchenne Muscular Dystrophy. Pediatr Neurol 1993;9(3):165-77.
9. Vignos P, Wagner M, Karlinchak B, Katirji B. Evaluation of a program for long-term treatment of Duchenne Muscular Dystrophy. J Bone Joint Surg 1996;78A(12):1844-52.
10. Brook M. A clinician's view of neuromuscular disease. USA: Williams & Wilkins; 1986.
11. Eagle M, Baudouin S, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne Muscular Dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromusc Disord 2002;12:926-9.
12. Department for Education and Employment. The Disability Discrimination Act 1995. Revised 2001.
13. Naidoo J, Wills J. Health promotion, foundations for practice. UK: Balliere Tindall; 1998.
14. Cormack D. The research process in nursing. 4th ed. UK: Blackwell Science; 2000.
15. Holroyd J, Guthrie D. Stress in families of children with neuromuscular disease. J Clin Psychol 1979;35(4):734-9.
16. Ahlstrom G, Gunnarsson LG. Disability and quality of life in individuals with muscular dystrophy. Scand J Rehabil Med 1996;28:147-57.
17. Bayrakal S. A group experience with chronically disabled adolescents. Am J Psychiatry 1975;132(12):1291-4.
18. Firth M, Gardner-Medwin D, Hosking G, Wilkinson E. Interviews of parents with boys suffering from Duchenne Muscular Dystrophy. Dev Med Child Neurol 1983;25:466-71.
19. Fitzpatrick C, Barry C. Cultural differences in family communication about Duchenne Muscular Dystrophy. Dev Med Child Neurol 1990;32:967-73.
20. Gagliardi B. The impact of Duchenne Muscular Dystrophy on families. Orthop Nurs 1991;10(5):41-9.
21. Gagliardi B. The family's experience of living with a child with Duchenne Muscular Dystrophy. Appl Nurs Res 1991;4(4):159-64.
22. Kornfield MS, Siegel IM. Parental group therapy in the management of a fatal childhood disease. Health Soc Work 1979;4(3):99-118.
23. Thompson RJ, Zemen JL, Fanurik D, Sirotkin-Roses M. The role of parent stress and coping and family functioning in parent and child adjustment to Duchenne Muscular Dystrophy. J Clin Psychol 1992;48(1):11-9.
24. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1986;89(2):2-35.
25. Department of Health. A health service of all talents: developing the NHS workforce. London: DoH; 2000.